![]() |
產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號(hào) | CS10748 |
應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 |
CAS編號(hào) | |
抗體名 | Anti-PIK3CA |
克隆性 | |
靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
宿主 | 詳見(jiàn)說(shuō)明書(shū) |
亞型 | IgG |
標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human PI3KCA C-terminus |
技術(shù)外包服務(wù):
★磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū) 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝:腺病毒、慢病毒等
★抗體工程:磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
實(shí)驗(yàn)流程:
磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū) 英文名稱(chēng) Anti-PIK3CA
中文名稱(chēng) 磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū)
別 名 PI3 kinase p110 subunit alpha; caPI3K; MGC142161; MGC142163; p110 alpha; p110 alpha; Phosphatidylinositol 3 kinase catalytic alpha polypeptide; Phosphatidylinositol 3 kinase catalytic 110 KD alpha; Phosphatidylinositol 4 5 bisphosphate 3 kinase catalytic subunit alpha isoform; Phosphoinositide 3 kinase catalytic alpha polypeptide; PI3 kinase p110 subunit alpha; PI3K; PI3KC A; PIK3C A; PIK3CA; PK3CA; PtdIns 3 kinase p110; PI3-kinase P110α; PI3-kinase p110 subunit alpha; PI 3 Kinase catalytic subunit alpha.
產(chǎn)品屬性:
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類(lèi)型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Cow, Rabbit
產(chǎn)品類(lèi)型 一抗
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 117kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human PI3KCA C-terminus
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū) 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 PI3-Kinases (PI3-Ks) are a family of lipid kinases that are implicated in signal transduction. Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. The p85 subunit localize PI3-K activity to the plasma membrane while the p110 subunit contains the catalytic domain of PI3-K which uses ATP to phosphorylate PtdIns, PtdIns4P and PtdInsP2. Four isoforms of p110 has been found; alpha, beta, gamma, and the delta subunit. The alpha isoform, also known as PI3KCA, is a transforming oncogene that was shown to have activating mutations in nine types of cancers such as colon, brain, breast and stomach.
Function : PI3K that phosphorylates PtdIns, PtdIns4P and PtdIns(4,5)P2 to generate PIP3. PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation in breast cancer cells through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. Has also serine-protein kinase activity: phosphorylates PIK3R1, EIF4EBP1 and HRAS.
Subunit : Heterodimer of a catalytic subunit PIK3CA and a p85 regulatory subunit (PIK3R1, PIK3R2 or PIK3R3). Interacts with IRS1 in nuclear extracts. Interacts with RUFY3. Interacts with RASD2. Interacts with APPL1. Interacts with HRAS1 and KRAS. Interaction with HRAS1/KRAS is required for PI3K pathway signaling and cell proliferation stimulated by EGF and FGF2.
Similarity : Belongs to the PI3/PI4-kinase family.
Contains 1 PI3K-ABD domain.
Contains 1 PI3K-RBD domain.
Contains 1 PI3K/PI4K domain.
Contains 1 PIK helical domain.
磷脂酰肌醇激酶(P110α亞單位)
全、新、優(yōu)、品、好四大特點(diǎn):
磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū) 全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。
新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。
好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
正在熱銷(xiāo)的相關(guān)產(chǎn)品:
Anti-ASPP1/FITC 熒光素標(biāo)記p53凋亡刺激蛋白1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-F1 operon positive regulatory protein(NT)/FITC 熒光素標(biāo)記耶爾森氏菌F1莢膜蛋白抗體(N端)IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh CNN2 平滑肌鈣調(diào)蛋白CNN2抗體 規(guī)格 0.2ml
OAT-1 (Organic anion transporter 1)mouse、rat 陰離子轉(zhuǎn)運(yùn)蛋白-1(大、小鼠同源:人源見(jiàn)bs-0606P) 0.5mg
IFT20 英文名稱(chēng): 細(xì)胞纖毛內(nèi)轉(zhuǎn)運(yùn)同源蛋白20抗體 0.2ml
Rhesus antibody Rh TSFP1/SP1 轉(zhuǎn)錄生長(zhǎng)因子SP1抗體 規(guī)格 0.1ml
Anti-F1 operon positive regulatory protein(NT)/FITC 熒光素標(biāo)記耶爾森氏菌F1莢膜蛋白抗體(N端)IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-IL-21R/FITC 熒光素標(biāo)記白介素21受體抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Anti-Phospho-RCC1 (Ser11) /FITC 熒光素標(biāo)記磷酸化染色體濃縮調(diào)控蛋白1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Anterior Gradient 2 前梯度同源蛋白2抗體 規(guī)格 0.1ml
Rabbit anti-mouse Kappa light chain/FITC FITC標(biāo)記的兔抗小鼠k鏈 0.1ml
GATAD1 英文名稱(chēng): 眼發(fā)育相關(guān)基因蛋白ODAG抗體 0.2ml
Rhesus antibody Rh Rabbit anti-human IgM whole serum 兔抗人IgM抗血清 規(guī)格 1ml
Anti-Phospho-RCC1 (Ser11) /FITC 熒光素標(biāo)記磷酸化染色體濃縮調(diào)控蛋白1抗體IgGMulti-class antibodies規(guī)格: 0.2ml
IAA ELISA Kit 大鼠自身抗體Multi-class antibodies規(guī)格: 48T
Anti-TGF-beta 2 轉(zhuǎn)移生長(zhǎng)因子β2抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh GNL1 鳥(niǎo)嘌呤核苷酸結(jié)合蛋白1抗體 規(guī)格 0.2ml
TLa(Human thymus-leukemia antigen) ELISA Kit 人胸腺抗原 96T
phospho-NEK9(Thr210) 英文名稱(chēng): 磷酸化絲酸/蘇酸蛋白激酶NEK9抗體 0.1ml
phospho-ATF2 (Thr55) 英文名稱(chēng): 磷酸化活化復(fù)制因子2抗體 0.1ml
Anti-TGF-beta 2 轉(zhuǎn)移生長(zhǎng)因子β2抗體Multi-class antibodies規(guī)格: 0.1ml
CL-0028AtT-20(小鼠細(xì)胞)5×106cells/瓶×2
OPALIN Others Human 人 OPALIN 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
胰酶/EDTA消化液T/E
SK-OV-3細(xì)胞,人細(xì)胞 大鼠皮層神經(jīng)元細(xì)胞,RN-c細(xì)胞 胃粘膜上皮細(xì)胞Many types of cells包裝:5 × 105次方(1ml)
G1(發(fā)綠色熒光的小鼠胚胎干細(xì)胞) 5×106cells/瓶×2
HPlEpC Pellet 人胎盤(pán)上皮細(xì)胞團(tuán)塊 > 1 mio.cells 人前脂肪細(xì)胞-內(nèi)臟cDNAHPA-v cDNA
CL-0026ARPE-19(人視網(wǎng)膜上皮細(xì)胞)5×106cells/瓶×2
TGFB1 Others Human 人 / 恒河猴 / 狗 TGF-beta 1 / TGFB1 CHO細(xì)胞裂解液 (陽(yáng)性對(duì)照)
胎牛血清FBS
黃牛皮膚細(xì)胞;BTA-S2 鼠巨噬細(xì)胞,Ana-1細(xì)胞 MOLT-4(急性淋巴母細(xì)胞細(xì)胞)
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM9402
OMD Others Mouse 小鼠 OMD / Osteomodulin 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
磷脂酰肌醇激酶催化亞單位A抗體說(shuō)明書(shū) ENPP2 Others Human 人 Autotaxin / ENPP2 / NPP2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
rRTEC, 大鼠腎小管上皮細(xì)胞
大鼠嗅鞘細(xì)胞完全培養(yǎng)基 100mL
DH82狗腎惡性癥細(xì)胞 DH82 dog kidney maligna histiocytosis cells MEM培養(yǎng)基(GIBCO)+10%FBS
IFNA5 Protein Human 重組人 IFNA5 / IFNaG / Ierferon alpha-G 蛋白 (Fc 標(biāo)簽)
NCI-H2227(人小細(xì)胞細(xì)胞) 5×106cells/瓶×2 FRhK-4(恒河猴胚腎細(xì)胞)